Polymatech IPO is set at ₹10,000 crore as the company pushes global expansion and electronics manufacturing. Valuation, funding, and growth plans explained.
News
NSE IPO Update 2026: SEBI May Issue NoC This Month, Chairman Signals Big Breakthrough
NSE IPO update: SEBI Chairman Tuhin Kanta Pandey says the NoC for NSE IPO may be issued within this month, marking a major step toward the long-awaited public listing.
ESDS Software IPO Approved by SEBI: 5 Crucial Investor Insights
ESDS Software IPO receives SEBI approval to raise ₹600 crore. This article explains ESDS Software IPO details, fund usage, business model, and investor outlook.
Cheelizza Rights Issue 2025 – 8 Powerful Investor Facts You Must Know
Cheelizza Rights Issue 2025 allows eligible shareholders to buy shares at ₹12 each in a 1:13 ratio. Know record date, eligibility, forms, payment details, and whether you should apply.
SoftBank-backed Meesho IPO: 10 Powerful Updates Investors Must Know in 2025
The SoftBank-backed Meesho IPO is set to raise up to $606 million in 2025. Explore key details, price band, financials, risks, and growth strategy behind the SoftBank-backed Meesho IPO.
December IPO 2025: Massive 15 IPOs Set to Hit Dalal Street This Week (Big Market Buzz)
December IPO 2025 is shaping into a blockbuster week with 15 IPOs worth over ₹7,000 crore and six listings lined up on Dalal Street. Here's the complete breakdown of mainboard and SME action.
Oyo IPO Update: Prism’s Bold ₹6,650 Crore Plan Signals a Major Comeback
Oyo IPO gets its biggest push yet as parent Prism calls an EGM to raise ₹6,650 crore, restructure capital and revive its long-delayed listing. Full breakdown of approvals, bonus issue, and next steps.
December IPO Rush 2025: India Gears Up for a Blockbuster Year-End
December IPO Rush 2025 is set to be India’s biggest year-end listing wave, with eight major IPOs aiming to raise over ₹30,000 crore. Get the full breakdown, valuations, and issue sizes.
PharmEasy Targets Profitability: 7 Powerful Moves Driving a Turnaround by FY27
PharmEasy targets profitability as its new CEO drives a profit-first strategy, cuts debt, boosts margins, and unlocks synergies across the group. Learn how PharmEasy plans to achieve EBITDA and PAT positivity by FY27.
LOHUM Pre IPO: Massive ₹1,000 Cr Boost Signals Powerful 2026 Listing Ahead
LOHUM Pre IPO round aims to raise ₹1,000 crore ahead of its 2026 IPO, led by I9 Capital and Singularity Ventures. Explore funding details, financial growth, investor list, and LOHUM’s path toward one of India’s most anticipated clean-tech listings.
